Last reviewed · How we verify

Xiaojin Pill — Competitive Intelligence Brief

Xiaojin Pill (Xiaojin Pill) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine (herbal formulation). Area: Oncology.

marketed Traditional Chinese medicine (herbal formulation) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Xiaojin Pill (Xiaojin Pill) — Zhejiang Provincial People's Hospital. Xiaojin Pill is a traditional Chinese medicine formulation that works through multiple herbal components to reduce inflammation and improve microcirculation.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Xiaojin Pill TARGET Xiaojin Pill Zhejiang Provincial People's Hospital marketed Traditional Chinese medicine (herbal formulation)
Naoxintong Capsule Naoxintong Capsule Chinese Academy of Medical Sciences, Fuwai Hospital marketed Traditional Chinese Medicine (herbal formulation)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine (herbal formulation) class)

  1. Zhejiang Provincial People's Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Xiaojin Pill — Competitive Intelligence Brief. https://druglandscape.com/ci/xiaojin-pill. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: